342 related articles for article (PubMed ID: 23293520)
1. Molecular targeting of liposomal nanoparticles to tumor microenvironment.
Zhao G; Rodriguez BL
Int J Nanomedicine; 2013; 8():61-71. PubMed ID: 23293520
[TBL] [Abstract][Full Text] [Related]
2. Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.
Abumanhal-Masarweh H; Koren L; Zinger A; Yaari Z; Krinsky N; Kaneti G; Dahan N; Lupu-Haber Y; Suss-Toby E; Weiss-Messer E; Schlesinger-Laufer M; Shainsky-Roitman J; Schroeder A
J Control Release; 2019 Feb; 296():1-13. PubMed ID: 30615983
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Challenges in development of targeted liposomal therapeutics.
Sawant RR; Torchilin VP
AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-responsive Smart Liposomes in Cancer Targeting.
Jain A; Jain SK
Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors.
Kuo PH; Teng YH; Cin AL; Han W; Huang PW; Wang LH; Chou YT; Yang JL; Tseng YL; Kao M; Chang MD
Drug Deliv; 2020 Dec; 27(1):542-555. PubMed ID: 32241176
[TBL] [Abstract][Full Text] [Related]
7. Tumor Microenvironment-Sensitive Liposomes Penetrate Tumor Tissue via Attenuated Interaction of the Extracellular Matrix and Tumor Cells and Accompanying Actin Depolymerization.
Suzuki S; Itakura S; Matsui R; Nakayama K; Nishi T; Nishimoto A; Hama S; Kogure K
Biomacromolecules; 2017 Feb; 18(2):535-543. PubMed ID: 28055201
[TBL] [Abstract][Full Text] [Related]
8. Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.
Guo C; Chen Y; Gao W; Chang A; Ye Y; Shen W; Luo Y; Yang S; Sun P; Xiang R; Li N
Theranostics; 2017; 7(3):775-788. PubMed ID: 28255366
[TBL] [Abstract][Full Text] [Related]
9. Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells.
Schiffelers RM; Storm G
Int J Pharm; 2008 Dec; 364(2):258-64. PubMed ID: 18773947
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vessels.
Asai T
Biol Pharm Bull; 2012; 35(11):1855-61. PubMed ID: 23123455
[TBL] [Abstract][Full Text] [Related]
11. Targeting anticancer drugs to tumor vasculature using cationic liposomes.
Abu Lila AS; Ishida T; Kiwada H
Pharm Res; 2010 Jul; 27(7):1171-83. PubMed ID: 20333455
[TBL] [Abstract][Full Text] [Related]
12. Ligation strategies for targeting liposomal nanocarriers.
Marqués-Gallego P; de Kroon AI
Biomed Res Int; 2014; 2014():129458. PubMed ID: 25126543
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive liposomes for drug delivery.
Lee Y; Thompson DH
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198148
[TBL] [Abstract][Full Text] [Related]
14. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
15. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor.
Abu Lila AS; Doi Y; Nakamura K; Ishida T; Kiwada H
J Control Release; 2010 Mar; 142(2):167-73. PubMed ID: 19861140
[TBL] [Abstract][Full Text] [Related]
16. Active targeting strategies for anticancer drug nanocarriers.
Basile L; Pignatello R; Passirani C
Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
[TBL] [Abstract][Full Text] [Related]
17. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
Alavi M; Hamidi M
Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
[TBL] [Abstract][Full Text] [Related]
18. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
19. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
Kumar P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
[TBL] [Abstract][Full Text] [Related]
20. Liposomal drug formulations. Rationale for development and what we can expect for the future.
Allen TM
Drugs; 1998 Nov; 56(5):747-56. PubMed ID: 9829150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
